Keywords: enrolment, complete, ph, iii, trial, aspreva/roche, cellcept

Enrolment complete in Ph III trial of Aspreva/Roche's CellCept in MG

Article | 05 December 2005

Print This

Canadian drugmaker Aspreva has completed enrollment of 176 patients in a Phase III clinical study to assess the safety and efficacy ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in